Headlands Technologies LLC Sells 5,097 Shares of Veeva Systems Inc. (NYSE:VEEV)

Headlands Technologies LLC trimmed its holdings in Veeva Systems Inc. (NYSE:VEEV) by 57.8% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 3,725 shares of the technology company’s stock after selling 5,097 shares during the quarter. Headlands Technologies LLC’s holdings in Veeva Systems were worth $783,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also modified their holdings of the company. MassMutual Private Wealth & Trust FSB lifted its position in Veeva Systems by 72.5% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 119 shares of the technology company’s stock worth $25,000 after purchasing an additional 50 shares during the period. Centricity Wealth Management LLC bought a new position in shares of Veeva Systems during the 4th quarter worth about $25,000. Smithfield Trust Co boosted its position in shares of Veeva Systems by 145.5% during the 4th quarter. Smithfield Trust Co now owns 135 shares of the technology company’s stock valued at $27,000 after acquiring an additional 80 shares in the last quarter. Retirement Wealth Solutions LLC bought a new stake in Veeva Systems in the fourth quarter valued at about $31,000. Finally, Avion Wealth raised its position in Veeva Systems by 635.0% in the fourth quarter. Avion Wealth now owns 147 shares of the technology company’s stock worth $30,000 after purchasing an additional 127 shares in the last quarter. Institutional investors and hedge funds own 88.20% of the company’s stock.

Insider Transactions at Veeva Systems

In other news, SVP Jonathan Faddis sold 787 shares of Veeva Systems stock in a transaction on Wednesday, April 2nd. The shares were sold at an average price of $226.20, for a total value of $178,019.40. Following the completion of the sale, the senior vice president now owns 8,668 shares in the company, valued at $1,960,701.60. The trade was a 8.32 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 10.50% of the stock is owned by corporate insiders.

Veeva Systems Stock Down 0.6 %

Shares of NYSE:VEEV opened at $226.51 on Thursday. The business has a fifty day simple moving average of $231.96 and a 200 day simple moving average of $223.04. Veeva Systems Inc. has a 12-month low of $170.25 and a 12-month high of $258.93. The firm has a market cap of $36.85 billion, a P/E ratio of 55.93, a P/E/G ratio of 1.89 and a beta of 0.88.

Analysts Set New Price Targets

Several equities analysts recently commented on VEEV shares. Wells Fargo & Company raised their target price on Veeva Systems from $275.00 to $285.00 and gave the stock an “overweight” rating in a research report on Friday, December 6th. Evercore ISI lifted their price objective on Veeva Systems from $220.00 to $245.00 and gave the company an “in-line” rating in a report on Friday, December 6th. KeyCorp lowered their target price on shares of Veeva Systems from $285.00 to $255.00 and set an “overweight” rating on the stock in a report on Wednesday, January 8th. StockNews.com raised shares of Veeva Systems from a “hold” rating to a “buy” rating in a report on Monday, February 17th. Finally, Stephens reaffirmed an “overweight” rating and set a $280.00 price objective on shares of Veeva Systems in a research note on Thursday, March 6th. Two investment analysts have rated the stock with a sell rating, eight have given a hold rating and sixteen have issued a buy rating to the company’s stock. According to data from MarketBeat, Veeva Systems has a consensus rating of “Moderate Buy” and an average price target of $256.52.

Veeva Systems Company Profile

Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.